Regenerative Medical Technology Group Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-2.9M | $-876.3K | $-1.3M | $-4.4M | $-1.4M | $-760.0K | $-638.2K | $-887.1K |
| Depreciation & Amortization | $90.8K | $97.7K | $98.3K | $76.1K | $54.8K | $51.8K | $-27.8K | $88.8K |
| Depreciation | $66.4K | $73.3K | $74.0K | $51.7K | $30.4K | $27.4K | $-52.2K | $64.4K |
| Amortization | $24.4K | $24.4K | $24.4K | $24.4K | $24.4K | $24.4K | — | — |
| Stock-Based Compensation | — | — | — | — | — | — | — | — |
| Net Cash from Operating Activities | $332.0K | $102.1K | $38.2K | $-203.7K | $-598.1K | $57.1K | $379.4K | $272.9K |
| Investing Activities | ||||||||
| Capital Expenditures | $43.5K | $315.4K | — | — | — | — | $50.0K | $53.6K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-43.5K | $-315.4K | — | — | — | — | $-50.0K | $-53.6K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $-26.6K | $318.0K | — | — | — | — | — | — |
| Net Change in Cash | — | — | — | — | — | — | — | — |
| Free Cash Flow | $288.5K | $-213.3K | — | — | — | — | $329.4K | $219.3K |